Heartseed (TSE:219A) Beneish M-Score: 14.92 (As of Sep. 07, 2026) — 131% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:219A Heartseed Inc TSE:219A
11 GF Score
Price 円2,236.00
! 2 Warning Signs
View Full Analysis

What is Heartseed Beneish M-Score?

Heartseed TSE:219A +2.95% 11 Beneish M-Score is 14.92 as of Sep. 07, 2026, which is 131% above its 10-year median of 6.46. GuruFocus rates TSE:219A with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 832 Biotechnology companies, Heartseed ranks worse than 94.35% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 14.92 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Heartseed's Beneish M-Score or its related term are showing as below:

TSE:219A' s Beneish M-Score Range Over the Past 10 Years
Min: -2.01   Med: 6.46   Max: 14.92
Current: 14.92

During the past 3 years, the highest Beneish M-Score of Heartseed was 14.92. The lowest was -2.01. And the median was 6.46.


Heartseed Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Heartseed's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heartseed Beneish M-Score Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24
Beneish M-Score
0.00 0.00 14.92

Heartseed Quarterly Data
Oct22 Oct23 Apr24 Jul24 Oct24 Apr25 Jul25 Oct25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -2.01 0.00 0.00

TSE:219A vs VRTX, REGN, MRNA: Beneish M-Score Comparison

For the Biotechnology subindustry, Heartseed's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heartseed Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heartseed's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Heartseed's Beneish M-Score falls into.


TSE:219A
11GF Score
Heartseed Inc TSE:219A
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heartseed Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Heartseed for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 18.1982+0.528 * 1+0.404 * 0.8093+0.892 * 2.5342+0.115 * 0.1834
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * 0.075035-0.327 * 0.9169
=14.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Oct24) TTM:Last Year (Oct23) TTM:
Total Receivables was 円798 Mil.
Revenue was 円874 Mil.
Gross Profit was 円874 Mil.
Total Current Assets was 円6,404 Mil.
Total Assets was 円7,068 Mil.
Property, Plant and Equipment(Net PPE) was 円456 Mil.
Depreciation, Depletion and Amortization(DDA) was 円42 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円282 Mil.
Long-Term Debt & Capital Lease Obligation was 円1 Mil.
Net Income was 円-813 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円-1,343 Mil.
Total Receivables was 円17 Mil.
Revenue was 円345 Mil.
Gross Profit was 円345 Mil.
Total Current Assets was 円5,028 Mil.
Total Assets was 円5,720 Mil.
Property, Plant and Equipment(Net PPE) was 円484 Mil.
Depreciation, Depletion and Amortization(DDA) was 円8 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円244 Mil.
Long-Term Debt & Capital Lease Obligation was 円6 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(798.31 / 873.61) / (17.31 / 344.725)
=0.913806 / 0.050214
=18.1982

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(344.725 / 344.725) / (873.61 / 873.61)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (6403.814 + 455.707) / 7067.594) / (1 - (5028.176 + 483.503) / 5719.751)
=0.02944 / 0.036378
=0.8093

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=873.61 / 344.725
=2.5342

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.571 / (7.571 + 483.503)) / (41.818 / (41.818 + 455.707))
=0.015417 / 0.084052
=0.1834

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 873.61) / (0 / 344.725)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.755 + 282.074) / 7067.594) / ((5.57 + 244.062) / 5719.751)
=0.040018 / 0.043644
=0.9169

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-812.725 - 0 - -1343.039) / 7067.594
=0.075035

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Heartseed has a M-score of 14.92 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 14.92 mean?
Heartseed (TSE:219A) has a Beneish M-Score of 14.92 as of Sep. 07, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Heartseed and its competitors. This is 131% above median its historical median of 6.46. According to the industry distribution chart, Heartseed ranks #785 out of 832 companies in the Biotechnology industry, placing it in the top 94.4%.
Is Heartseed's Beneish M-Score too high?
Heartseed's current Beneish M-Score of 14.92 is 131% above median its 10-year median of 6.46. Based on the distribution chart, Heartseed ranks #785 out of 832 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Heartseed has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Heartseed's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Heartseed ranks #785 out of 832 companies for Beneish M-Score. This places Heartseed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Heartseed and its competitors. Heartseed's current Beneish M-Score is 14.92, which is 131% above median its own 10-year median of 6.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Heartseed stock overvalued right now?
Heartseed (TSE:219A) has a current Beneish M-Score of 14.92. The current Beneish M-Score is 14.92, which is 131% above median its 10-year median of 6.46. Heartseed's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Heartseed (TSE:219A), the current Beneish M-Score is 14.92 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Heartseed Business Description

Address 1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy.
11GF Score

Get the complete analysis for TSE:219A

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,236.00
Price